This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Chu Nantes, National Institute of Health and Medical Research. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2023
Title: Agnes Quemenier: Innovator in Bronchodilation Treatments
Introduction
Agnes Quemenier is a notable inventor based in Nantes, France. She has made significant contributions to the field of medical research, particularly in the development of treatments for bronchoconstriction-related pathologies such as asthma. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to improving respiratory health.
Latest Patents
Agnes Quemenier holds a patent for "Inhibitors of RAC1 and uses thereof for inducing bronchodilatation." This invention concerns a compound designed to treat conditions characterized by bronchoconstriction. The compound has a specific formula that includes various chemical groups aimed at enhancing bronchodilation, thereby providing relief for patients suffering from asthma and similar conditions.
Career Highlights
Throughout her career, Agnes has worked with prestigious institutions such as the National Institute of Health and Medical Research and the Centre National de la Recherche Scientifique. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Agnes has collaborated with notable colleagues, including Vincent Sauzeau and Gervaise Loirand. These partnerships have enriched her research and have been instrumental in advancing her innovative projects.
Conclusion
Agnes Quemenier's contributions to the field of bronchodilation treatments highlight her role as a pioneering inventor. Her patent and collaborative efforts reflect her commitment to enhancing respiratory health and improving the lives of those affected by asthma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile